STI Expert Hour Webinar – Urogenital Gonorrhea

May 15, 2026
12:00PM-1:15PM (PDT)
1.25 CME units at no cost
Registration closes on May 14, 2026 at 3:00PM (PDT)

Course Description

The FDA has recently approved two new oral treatments for urogenital gonorrhea. But what is the data behind these approvals, and what does this mean for clinical practice? Come join this STI expert hour to learn more!

Presenter

Katherine Yang, PharmD, MPH
Professor, Department of Clinical Pharmacy, University of California (UCSF) School of Pharmacy Infectious Diseases Clinical Pharmacist, UCSF Medical Center

Learning Objectives

• Describe the mechanisms of action and antimicrobial activity of zoliflodacin and gepotidacin against Neisseria gonorrhoeae, including their effectiveness against drug-resistant strains
• Compare the clinical efficacy, safety profiles, and potential roles of zoliflodacin and gepotidacin in the treatment of gonorrhea